MEGAN MCCLELLAN: Open Payments
NPI 1740795194 · CARBONDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,597 in 93 payments from 17 companies in 2025. Trend: 2023 $431 · 2024 $1,016 · 2025 $1,597
Food & beverage: $1,597
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $366 |
| Phathom Pharmaceuticals, Inc. | 27 | $324 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $118 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $104 |
| Madrigal Pharmaceuticals | 5 | $102 |
| Aimmune Therapeutics, Inc. | 4 | $96 |
| Ardelyx, Inc. | 4 | $74 |
| GENZYME CORPORATION | 3 | $71 |
| Novo Nordisk Inc | 4 | $71 |
| Ipsen Biopharmaceuticals, Inc | 3 | $53 |
Products named: VOQUEZNA, RINVOQ, LINZESS, XIFAXAN, ENTYVIO, REZDIFFRA, ZENPEP, IBSRELA.
Industry payments across IL — which companies pay providers there.
